|
Volumn 76, Issue 2, 2003, Pages 478-481
|
Cardiac valve replacement in human immunodeficiency virus-infected patients
c
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADULT;
AORTA VALVE REPLACEMENT;
ARTICLE;
BIOPROSTHESIS;
CAUSE OF DEATH;
CLINICAL ARTICLE;
ENDOCARDITIS;
FEMALE;
HAEMOPHILUS;
HEART FAILURE;
HEART VALVE PROSTHESIS;
HEART VALVE REPLACEMENT;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION RISK;
INTRAVENOUS DRUG ABUSE;
MALE;
MITRAL VALVE REPLACEMENT;
PRIORITY JOURNAL;
PSEUDOMONAS;
SEPSIS;
STAPHYLOCOCCUS;
STREPTOCOCCUS;
SURVIVAL RATE;
TREATMENT INDICATION;
TREATMENT OUTCOME;
VALVULAR HEART DISEASE;
VIRUS INFECTION;
ADULT;
BIOPROSTHESIS;
COHORT STUDIES;
FEMALE;
FOLLOW-UP STUDIES;
HEART VALVE DISEASES;
HEART VALVE PROSTHESIS;
HEART VALVE PROSTHESIS IMPLANTATION;
HEART VALVES;
HIV INFECTIONS;
HUMANS;
INCIDENCE;
MALE;
MIDDLE AGED;
PROSTHESIS FAILURE;
PROSTHESIS-RELATED INFECTIONS;
RETROSPECTIVE STUDIES;
RISK ASSESSMENT;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0042659380
PISSN: 00034975
EISSN: None
Source Type: Journal
DOI: 10.1016/S0003-4975(03)00514-9 Document Type: Article |
Times cited : (28)
|
References (7)
|